Moreover, the blockade of tumor necrosis factor (TNF)-α reduced CD47 and increased phagocytosis, suggesting that the TNF-NF-κB signaling pathway directly governs CD47, by interacting with a constituent enhancer placed within a CD47-associated SE specific to breast cancer. Here, NFKB1 is linked to breast carcinoma.